The Role of Inflammation in Ischemic Organ Injury

炎症在缺血性器官损伤中的作用

基本信息

  • 批准号:
    8214657
  • 负责人:
  • 金额:
    $ 19.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-02-01 至 2012-10-01
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The study examines the role of toll-like receptor 2 (TLR2)-mediated signals in a murine model of renal ischemia reperfusion (IR) injury. Experimental renal IR injury mimics ischemic acute kidney injury, a major cause of morbidity and mortality in hospitalized patients. The overall HYPOTHESIS to be tested is that TLR2 plays a primary role in the pathogenesis of renal IR injury by directly and/or indirectly contributing to renal tubular cell injury. Specific Aims: (1) Determine whether TLR2-mediated signals directly injure tubular epithelial cells and define the mechanisms of cell injury; (2) Determine whether TLR2 ligation contributes to IR injury through direct (local) or indirect (systemic) effects; (3) Determine whether TLR2 ligation contributes to IR injury through activation of adaptive immunity. Significance: Ischemia reperfusion injury is a common cause of acute renal failure in hospitalized patients and is directly linked to an increase in morbidity and mortality. Despite extensive research, the mechanisms of renal injury remain elusive and more importantly there are no effective prophylactic regimens or treatments for established disease, other than supportive care. Recognition that ischemic tissue releases molecules that trigger tissue injury through TLRs has opened a new field of research. The PI's laboratory has found that one TLR, TLR2, is highly expressed in the region of the kidney that is most sensitive to renal IR injury. If TLR2 is found to be the key participant in either local or systemic phases of renal IR injury, then TLR2 directed strategies would be pursued for both prophylaxis and treatment of ischemic renal injury.
描述(由申请人提供):研究检查了类似收费的受体2(TLR2)介导的信号在肾脏缺血再灌注(IR)损伤的鼠模型中的作用。实验性肾脏IR损伤模仿缺血性急性肾脏损伤,这是住院患者发病率和死亡率的主要原因。要测试的总体假设是,TLR2通过直接和/或间接促进肾小管细胞损伤而在肾脏IR损伤的发病机理中起主要作用。具体目的:(1)确定TLR2介导的信号是否直接损害管状上皮细胞并定义细胞损伤的机制; (2)确定TLR2连接是否通过直接(局部)或间接(全身)效应造成IR损伤; (3)确定TLR2连接是否通过激活适应性免疫有助于IR损伤。意义:缺血再灌注损伤是住院患者急性肾衰竭的常见原因,与发病率和死亡率的增加直接相关。尽管进行了广泛的研究,但除支持性护理以外,肾脏损伤的机制仍然难以捉摸,更重要的是,没有有效的预防治疗方案或治疗已建立疾病的治疗方法。认识到缺血组织释放通过TLR引发组织损伤的分子已开辟了一个新的研究领域。 PI的实验室发现,一个TLR TLR2在肾脏最敏感的肾脏IR损伤的区域中高度表达。如果发现TLR2是肾脏IR损伤的局部或全身阶段的关键参与者,则将针对预防和治疗缺血性肾脏损伤的TLR2指示策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dianne B Mckay其他文献

Dianne B Mckay的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dianne B Mckay', 18)}}的其他基金

Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
  • 批准号:
    10555070
  • 财政年份:
    2021
  • 资助金额:
    $ 19.46万
  • 项目类别:
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
  • 批准号:
    10659033
  • 财政年份:
    2021
  • 资助金额:
    $ 19.46万
  • 项目类别:
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
  • 批准号:
    10844207
  • 财政年份:
    2021
  • 资助金额:
    $ 19.46万
  • 项目类别:
JAML-CAR regulation of adipose tissue homeostasis
JAML-CAR对脂肪组织稳态的调节
  • 批准号:
    10348218
  • 财政年份:
    2021
  • 资助金额:
    $ 19.46万
  • 项目类别:
JAML-CAR regulation of adipose tissue homeostasis
JAML-CAR对脂肪组织稳态的调节
  • 批准号:
    10217488
  • 财政年份:
    2021
  • 资助金额:
    $ 19.46万
  • 项目类别:
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
  • 批准号:
    10494248
  • 财政年份:
    2021
  • 资助金额:
    $ 19.46万
  • 项目类别:
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
NLRP3信号在缺血/再灌注引起的器官损伤中的作用
  • 批准号:
    10375997
  • 财政年份:
    2021
  • 资助金额:
    $ 19.46万
  • 项目类别:
AIM2 as a negative regulator of renal ischemia/reperfusion injury
AIM2 作为肾缺血/再灌注损伤的负调节因子
  • 批准号:
    10043487
  • 财政年份:
    2020
  • 资助金额:
    $ 19.46万
  • 项目类别:
AIM2 as a negative regulator of renal ischemia/reperfusion injury
AIM2 作为肾缺血/再灌注损伤的负调节因子
  • 批准号:
    10170263
  • 财政年份:
    2020
  • 资助金额:
    $ 19.46万
  • 项目类别:
Role of NOD2 in ischemia reperfusion injury
NOD2在缺血再灌注损伤中的作用
  • 批准号:
    9750718
  • 财政年份:
    2017
  • 资助金额:
    $ 19.46万
  • 项目类别:

相似海外基金

Particulate exposure and kidney health: Diversity Supplement Villarreal Hernandez
颗粒物暴露与肾脏健康:多样性补充剂 Villarreal Hernandez
  • 批准号:
    10770032
  • 财政年份:
    2023
  • 资助金额:
    $ 19.46万
  • 项目类别:
Ceramides as Novel Mediators of Tubular Metabolic Dysfunction Driving Kidney Injury
神经酰胺作为肾小管代谢功能障碍驱动肾损伤的新型调节剂
  • 批准号:
    10677394
  • 财政年份:
    2023
  • 资助金额:
    $ 19.46万
  • 项目类别:
Resource Development Core
资源开发核心
  • 批准号:
    10746903
  • 财政年份:
    2023
  • 资助金额:
    $ 19.46万
  • 项目类别:
Acute Kidney Injury in Children with Chronic Kidney Disease
慢性肾病儿童的急性肾损伤
  • 批准号:
    10638267
  • 财政年份:
    2023
  • 资助金额:
    $ 19.46万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10746569
  • 财政年份:
    2023
  • 资助金额:
    $ 19.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了